AIM: To identify the novel methylation-silenced gene pentraxin 3 (PTX3) in esophageal squamous cell carcinoma (ESCC). METHODS: PTX3 mRNA expression was examined in six human ESCC cell lines, one human immortalized normal esophageal epithelial cell line, primary ESCC tumor tissue, and paired adjacent nontumor tissue using reverse transcription polymerase chain reaction (RT-PCR). Semi-quantitative immunohistochemistry was used to examine cellular localisation and protein levels. Methylation specific PCR and bisulphite genomic sequencing were employed to investigate the methylation of the candidate gene. RESULTS: In the majority of ESCC cell lines, we found that PTX3 expression was down-regulated due to gene promoter hypermethylation, which was further confirmed by bisulphite genomic sequencing. Demethylation treatment with 5-aza-2'-deoxycytidine restored PTX3 mRNA expression in ESCC cell lines. Methylation was more common in tumor tissues (85%) than in adjacent nontumor tissues (25%) (P < 0 .01). CONCLUSION: PTX3 is down-regulated through promoter hypermethylation in ESCC, and could potentially serve as a biomarker of ESCC.
AIM: To identify the novel methylation-silenced gene pentraxin 3 (PTX3) in esophageal squamous cell carcinoma (ESCC). METHODS:PTX3 mRNA expression was examined in six human ESCC cell lines, one human immortalized normal esophageal epithelial cell line, primary ESCC tumor tissue, and paired adjacent nontumor tissue using reverse transcription polymerase chain reaction (RT-PCR). Semi-quantitative immunohistochemistry was used to examine cellular localisation and protein levels. Methylation specific PCR and bisulphite genomic sequencing were employed to investigate the methylation of the candidate gene. RESULTS: In the majority of ESCC cell lines, we found that PTX3 expression was down-regulated due to gene promoter hypermethylation, which was further confirmed by bisulphite genomic sequencing. Demethylation treatment with 5-aza-2'-deoxycytidine restored PTX3 mRNA expression in ESCC cell lines. Methylation was more common in tumor tissues (85%) than in adjacent nontumor tissues (25%) (P < 0 .01). CONCLUSION:PTX3 is down-regulated through promoter hypermethylation in ESCC, and could potentially serve as a biomarker of ESCC.
Authors: J F Costello; M C Frühwald; D J Smiraglia; L J Rush; G P Robertson; X Gao; F A Wright; J D Feramisco; P Peltomäki; J C Lang; D E Schuller; L Yu; C D Bloomfield; M A Caligiuri; A Yates; R Nishikawa; H Su Huang; N J Petrelli; X Zhang; M S O'Dorisio; W A Held; W K Cavenee; C Plass Journal: Nat Genet Date: 2000-02 Impact factor: 38.330
Authors: Adriana C Soares; Danielle G Souza; Vanessa Pinho; Angélica T Vieira; Jacques R Nicoli; Fernando Q Cunha; Alberto Mantovani; Luiz Fernando L Reis; Adriana A M Dias; Mauro M Teixeira Journal: Microbes Infect Date: 2006-03-24 Impact factor: 2.700
Authors: Irfana Salam; Showket Hussain; Mohammad Muzaffar Mir; Nazir Ahmad Dar; Safiya Abdullah; Mushtaq Ahmad Siddiqi; Riyaz Ahmad Lone; Showkat Ahmad Zargar; Shashi Sharma; Suresh Hedau; Seemi Farhat Basir; Alok Chandra Bharti; Bhudev C Das Journal: Mol Cell Biochem Date: 2009-06-10 Impact factor: 3.396
Authors: Clémence Thomas; Whitney Henry; Benjamin G Cuiffo; Anthony Y Collmann; Elisabetta Marangoni; Vanessa Benhamo; Manoj K Bhasin; Cheng Fan; Laetitia Fuhrmann; Albert S Baldwin; Charles Perou; Anne Vincent-Salomon; Alex Toker; Antoine E Karnoub Journal: Sci Signal Date: 2017-02-21 Impact factor: 8.192
Authors: Cecilia Garlanda; Barbara Bottazzi; Elena Magrini; Antonio Inforzato; Alberto Mantovani Journal: Physiol Rev Date: 2018-04-01 Impact factor: 37.312
Authors: Daniel S Peiffer; Noah P Zimmerman; Li-Shu Wang; Benjamin W S Ransom; Steven G Carmella; Chieh-Ti Kuo; Jibran Siddiqui; Jo-Hsin Chen; Kiyoko Oshima; Yi-Wen Huang; Stephen S Hecht; Gary D Stoner Journal: Cancer Prev Res (Phila) Date: 2014-03-25